Published in Influenza Other Respir Viruses on April 02, 2013
The manufacturing process should remain the focus for severe febrile reactions in children administered an Australian inactivated influenza vaccine during 2010. Influenza Other Respir Viruses (2016) 0.78
Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial. Hum Vaccin Immunother (2016) 0.75
Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01
Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med (2009) 6.88
Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol (2005) 5.66
Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med (2009) 5.46
Evidence of human metapneumovirus in Australian children. Med J Aust (2002) 3.65
Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J Med Virol (2006) 3.50
Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA (2009) 3.32
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis (2008) 3.05
Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis (2009) 2.99
Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine (2012) 2.98
The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ (2005) 2.52
Comparing nose-throat swabs and nasopharyngeal aspirates collected from children with symptoms for respiratory virus identification using real-time polymerase chain reaction. Pediatrics (2008) 2.37
Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C). PLoS One (2008) 2.23
A sensitive, specific, and cost-effective multiplex reverse transcriptase-PCR assay for the detection of seven common respiratory viruses in respiratory samples. J Mol Diagn (2004) 2.21
Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. Eur J Pediatr (2005) 2.20
Community epidemiology of human metapneumovirus, human coronavirus NL63, and other respiratory viruses in healthy preschool-aged children using parent-collected specimens. Pediatrics (2007) 2.13
Introducing a new group B meningococcus vaccine. BMJ (2014) 2.13
Further evidence that the IS481 target is suitable for real-time PCR detection of Bordetella pertussis. Pathology (2013) 2.13
Nutritional status and nutrition risk screening in hospitalized children in New Zealand. Acta Paediatr (2013) 2.09
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis (2012) 2.05
New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol (2005) 2.04
Paediatric empyema in New Zealand: a tale of two cities. N Z Med J (2015) 1.99
Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect Dis (2011) 1.98
Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust (2009) 1.97
Prevention of influenza at Hajj: applications for mass gatherings. J R Soc Med (2013) 1.95
Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol (2012) 1.85
A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic. PLoS One (2008) 1.84
Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Math Biosci (2007) 1.82
Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis (2003) 1.76
Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol (2009) 1.75
Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J (2011) 1.72
Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology (2012) 1.65
A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity. PLoS One (2007) 1.64
Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respir Viruses (2009) 1.60
Hospitalisation for bronchiolitis in infants is more common after elective caesarean delivery. Arch Dis Child (2011) 1.56
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. Vaccine (2008) 1.52
Hajj: health lessons for mass gatherings. J Infect Public Health (2008) 1.46
The burden of influenza in children. Curr Opin Infect Dis (2007) 1.44
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine (2008) 1.43
Evaluation of the cobas 4800 CT/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Infect (2010) 1.43
Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. J Med Microbiol (2004) 1.43
Molecular surveillance of true nontypeable Haemophilus influenzae: an evaluation of PCR screening assays. PLoS One (2012) 1.42
Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom. Clin Infect Dis (2009) 1.42
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine (2008) 1.40
Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg Infect Dis (2009) 1.39
Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks. BMC Infect Dis (2010) 1.38
Pericarditis after meningococcal infection: case report of a child with two distinct episodes. Pediatr Infect Dis J (2004) 1.38
Antibody persistence in Australian adolescents following meningococcal C conjugate vaccination. Pediatr Infect Dis J (2015) 1.38
Impact of competitive inhibition and sequence variation upon the sensitivity of malaria PCR. J Clin Microbiol (2007) 1.37
Ethnicity, social deprivation and psychological distress in adolescents: school-based epidemiological study in east London. Br J Psychiatry (2004) 1.35
A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers. Malar J (2011) 1.32
Flinders Island spotted fever rickettsioses caused by "marmionii" strain of Rickettsia honei, Eastern Australia. Emerg Infect Dis (2007) 1.30
Influenza among U.K. pilgrims to hajj, 2003. Emerg Infect Dis (2004) 1.29
A newly reported human polyomavirus, KI virus, is present in the respiratory tract of Australian children. J Clin Virol (2007) 1.28
Influenza: accounting for prior immunity. Science (2009) 1.28
Norovirus excretion in an aged-care setting. J Clin Microbiol (2008) 1.27
Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs. PLoS One (2008) 1.26
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis (2008) 1.26
Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza Other Respir Viruses (2011) 1.24
Detection of BK, JC, WU, or KI polyomaviruses in faecal, urine, blood, cerebrospinal fluid and respiratory samples. J Clin Virol (2009) 1.24
Use of the P gene to genotype human metapneumovirus identifies 4 viral subtypes. J Infect Dis (2004) 1.23
Prevention of pandemic influenza after mass gatherings - learning from Hajj. J R Soc Med (2010) 1.22
Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ (2006) 1.21
Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn Microbiol Infect Dis (2008) 1.21
Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother (2010) 1.20
Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model. PLoS Pathog (2013) 1.20
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. J Infect Dis (2011) 1.20
Human metapneumovirus, Australia, 2001-2004. Emerg Infect Dis (2006) 1.18
A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J Infect Dis (2010) 1.18
The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother (2012) 1.17
A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis (2008) 1.17
Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother (2010) 1.16
Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9. BMC Infect Dis (2010) 1.14
Ethnicity, socio-economic status, overweight and underweight in East London adolescents. Ethn Health (2005) 1.14
Variations in associations of health risk behaviors among ethnic minority early adolescents. J Adolesc Health (2006) 1.12
Haemophilus influenzae type b epiglottitis. Article gives timely lesson. BMJ (2003) 1.09
Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis. Influenza Other Respir Viruses (2011) 1.08
Longitudinal risk factors for persistent fatigue in adolescents. Arch Pediatr Adolesc Med (2008) 1.08
Detection of human bocavirus in respiratory, fecal, and blood samples by real-time PCR. J Med Virol (2009) 1.08
Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis (2012) 1.07
Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: A Case-Control Study. Pediatr Infect Dis J (2011) 1.07
Nasopharyngeal carriage of Haemophilus haemolyticus in otitis-prone and healthy children. J Clin Microbiol (2010) 1.07
The burden of childhood influenza in a tertiary paediatric setting. Commun Dis Intell Q Rep (2009) 1.06
Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med Sci Sports Exerc (2007) 1.06
Influenza vaccine uptake among British Muslims attending Hajj, 2005 and 2006. BMJ (2006) 1.04
Genetic diversity of human metapneumovirus over 4 consecutive years in Australia. J Infect Dis (2006) 1.04
Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea. Vaccine (2009) 1.04
Epidemiology of health and illness. BMJ (2005) 1.03